Benzofuran derivatives: A patent review

Expert Opinion on Therapeutic Patents

Volumn 23, Issue 9, 2013, Pages 1133-1156

  Dawood, Kamal M ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Anti inflammatory; Antimicrobial; Antitumor; Benzofurans; Cytotoxic; HCV; HIV inhibitory

Indexed keywords

AILANTHIOIDOL; AMIODARONE; ANASTROZOLE; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; AROMATASE; ATEVIRDINE; BENZOFURAN DERIVATIVE; BUFURALOL; CARRAGEENAN; CHALCONE; CICERFURAN; COMBRETASTATIN A4; CONOCARPAN; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; CYTARABINE; DICLOFENAC; DOXORUBICIN; FENAMIC ACID DERIVATIVE; FLUOROURACIL; FORMALDEHYDE; HYDROCORTISONE; LIGNAN DERIVATIVE; N [ 5 ( 2 BROMOBENZYL)THIAZOL 2 YL]BENZOFURAN 2 CARBOXAMIDE; PEPTIDE DEFORMYLASE INHIBITOR; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTAGLANDIN E2; THIAZOLE DERIVATIVE; TYLOXAPOL; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANALGESIA; ANTIBACTERIAL ACTIVITY; ANTIMALARIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; APOPTOSIS; CANCER CELL; CANCER CELL CULTURE; CELL PROLIFERATION; CHEMICAL STRUCTURE; CYTOTOXICITY; DRUG EFFICACY; DRUG POTENCY; DRUG SOLUBILITY; DRUG SYNTHESIS; ENZYME INHIBITION; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IC 50; IN VITRO STUDY; IN VIVO STUDY; INSECTICIDAL ACTIVITY; MICROTUBULE ASSEMBLY; NEUTROPHIL; NONHUMAN; PATENT; PAW EDEMA; REVIEW; STRUCTURE ACTIVITY RELATION; T LYMPHOCYTE; TRADITIONAL MEDICINE; TUMOR CELL LINE; VIRUS STRAIN;

ANIMALS; BENZOFURANS; DRUG DESIGN; HUMANS; PATENTS AS TOPIC; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84882754229     PISSN: 13543776     EISSN: 17447674     Source Type: Journal    
DOI: 10.1517/13543776.2013.801455     Document Type: Review

References (107)

1. Aslam SN, Stevenson PC, Phythian SJ, et al. Synthesis of cicerfuran, an antifungal benzofuran, and some related analogues. Tetrahedron 2006;62:4214-26
2. de Campos MP, Filho VC, da Silva RZ. Evaluation of antifungal activity of piper solmsianum C. DC. var. solmsianum (Piperaceae). Biol Pharm Bull 2005;28:1527-30
3. Kao CL, Chern JW. A convenient synthesis of naturally occurring benzofuran ailanthoidol. Tetrahedron Lett 2001;42:1111-13
4. Carlsson B, Singh BN, Temciuc M, et al. Synthesis and preliminary characterization of a novel antiarrhythmic compound (KB130015) with an improved toxicity profile compared with amiodarone. J Med Chem 2002;45:623-30
5. Spaniol M, Bracher R, Ha HR, et al. Toxicity of amiodarone analogues on isolated rat liver mitochondria. J Hepatol 2001;35:628-36
6. Narimatsu S, Takemi C, Kuramoto S, et al. Stereoselectivity in the oxidation of bufuralol, a chiral substrate, by human cyctochrome P450s. Chirality 2003;15:333-9
7. Hansott B, Greger H, Marian B. Naturally occurring lignans efficiently induce apoptosis in colorectal tumor cells. J Cancer Res Clin Oncol 2003;129:569-76
8. Ragab FAF, Eid NM, Hassan GS, Nissan YM. Synthesis and anti-inflammatory activity of some benzofuran and benzopyran-4-one derivatives. Chem Pharm Bull 2012;60:110-20
9. Mane BY, Vidyadhara S. Synthesis and screening of anti-inflammatory activity of benzofuran derivatives bearing oxadiazole. Orient J Chem 2011;27:1227-31
10. Baumgartner L, Sosa S, Atanasov AG, et al. Lignan derivatives from Krameria lappacea roots inhibit acute inflammation in vivo and pro-inflammatory mediators in vitro. J Nat Prod 2011;74:1779-86
11. Wu S-F, Chang F-R, Wang S-Y, et al. Anti-inflammatory and cytotoxic neoflavonoids and benzofurans from Pterocarpus santalinus. J Nat Prod 2011;74:989-96
12. Hu Z-F, Chen L-L, Qi J, et al. Two new benzofuran derivatives with anti-inflammatory activity from Liriope spicata var. prolifera. Fitoterapia 2011;82:190-2
13. Soman SS, Patel JM. One-pot synthesis of furoflavanones. Indian J Heterocycl Chem 2010;19:209-14
14. Heidari MR, Foroumadi A, Noroozi H, et al. Study of the anti-inflammatory and analgesic effects of novel rigid benzofuran-3,4-dihydroxy chalcone by formalin, hot-plate and carrageenan tests in mice. Pak J Pharm Sci 2009;22:395-401
15. Dawood KM, Abdel-Gawad H, Rageb EA, et al. Synthesis, anticonvulsant, and anti-inflammatory evaluation of some new benzotriazole and benzofuran-based heterocycles. Bioorg Med Chem 2006;14:3672-80
16. Dawood KM, Abdel-Gawad H, Ellithey M, et al. Synthesis, anticonvulsant, and anti-inflammatory activities of some new benzofuran-based heterocycles. Arch Pharm (Weinheim) 2006;339:133-40
17. Baumann B, Bohnenstengel F, Siegmund D, et al. Rocaglamide derivatives are potent inhibitors of NF-kappa B activation in T-cells. J Biol Chem 2002;277:44791-800
18. Yacovan A, Garzon A, Grynszpan F, et al. Tetracyclic benzofuran derivatives with therapeutic activities and their preparation and pharmaceutical composition. WO2007020631A220070222; 2007
19. Song W-J, Yang X-D, Zeng X-H. Synthesis and cytotoxic activities of novel hybrid compounds of imidazole scaffold-based 2-substituted benzofurans. R Soc Chem Adv 2012;2:4612-15
20. Choi M-J, Jung KH, Kim D, et al. Anti-cancer effects of a novel compound HS-113 on cell growth, apoptosis, and angiogenesis in human hepatocellular carcinoma cells. Cancer Lett 2011;306:190-6
21. Flynn BL, Gill GS, Grobelny DW, et al. Discovery of 7-hydroxy-6-methoxy- 2- methyl-3-(3,4,5-trimethoxybenzoyl)benzo [b]furan (BNC105), a tubulin polymerization inhibitor with potent antiproliferative and tumor vascular disrupting properties. J Med Chem 2011;54:6014-27
22. Antczak C, Shum D, Bassit B, et al. Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylase. Bioorg Med Chem Lett 2011;21:4528-32
23. Atta SMS, Farrag DS, Sweed AMK, Abdel-Rahman AH. Preparation of new polycyclic compounds derived from benzofurans and furochromones. An approach to novel 1,2,3-thia-, and selena-diazolofurochromones of anticipated antitumor activities. Eur J Med Chem 2010;45:4920-7
24. Manna SK, Bose JS, Gangan V, et al. Novel derivative of benzofuran induces cell death mostly by G2/M cell cycle arrest through p53-dependent pathway but partially by inhibition of NF-kB. J Biol Chem 2010;285:22318-27
25. Bose JS, Gangan V. Cinnamic acid, vanillic acid, and benzofuran compounds as chemotherapeutic agents against inflammation and cancer. WO2008062466A220080529; 2008
26. Koyama J, Morita I, Yamori T. Correlation between cytotoxic activities and reduction potentials of heterocyclic quinones. Molecules 2010;15:6559-69
27. Kaldrikyan MA, Grigoryan LA, Melik-Ogandzhanyan RG, Arsenyan FG. Synthesis and antitumor activity of some benzofuryl-substituted 1,2,4-triazoles. Pharm Chem J 2009;43:242-4
28. Galal SA, Abd El-All AS, Abdallah MM, El-Diwani HI. Synthesis of potent antitumor and antiviral benzofuran derivatives. Bioorg Med Chem Lett 2009;19:2420-8
29. Asoh K, Kohchi M, Hyoudoh I, et al. Synthesis and structure-Activity relationships of novel benzofuran farnesyltransferase inhibitors. Bioorg Med Chem Lett 2009;19:1753-7
30. Rida SM, El-Hawash SAM, Fahmy HTY, et al. Synthesis and in vitro evaluation of some novel benzofuran derivatives as potential anti-HIV-1, anticancer, and antimicrobial agents. Arch Pharm Res 2005;29:16-25
31. Mader MM, Shih C, Considine E, et al. Acyl sulfonamide anti-proliferatives. Part 2: Activity of heterocyclic sulfonamide derivatives. Bioorg Med Chem Lett 2005;15:617-20
32. Kremmidiotis G. Treatment of macular degeneration using a benzofuran-based compound. WO2011022781A120110303; 2011
33. Simoni D, Romagnoli R, Baruchello R, et al. Novel combretastatin analogues endowed with antitumor activity. J Med Chem 2006;49:3143-52
34. Liu JY, Ye YH, Wang L, et al. New resveratrol oligomers from the stem bark of Hopea hainanensis. Helv Chim Acta 2005;88:2910-17
35. Yan F, Wang A, Jia Z. Benzofuran derivatives from Ligularia stenocephala. J Chin Chem Soc 2004;51:863-8
36. Fukuda Y, Furuta H, Kusama Y, et al. Novel cyclopropapyrroloindole derivative (AT-3510) bearing methoxycarbonyl and trifluoromethyl groups. J Med Chem 1999;4:1448-58
37. Pieters L, Van Dyck S, Gao M, et al. Synthesis and biological evaluation of dihydrobenzofuran lignans and related compounds as potential antitumor agents that inhibit tubulin polymerization. J Med Chem 1999;42:5475-81
38. Asakawa K, Hashimoto M, Ito H, et al. Preparation of novel spiro Indian derivatives as protein kinase RSK1 inhibitors and antitumor agents. JP2009173629A20090806; 2009
39. Nagano T, Okabe T, Kojima H, et al. Preparation of 2-[(1H-indol-3-yl) methylene]benzofuran-3(2H)-one derivatives and their azaindole analogs as selective pim-1 kinase inhibitors and anticancer agents. WO2011136319A120111103; 2011
40. Weber O, Voehringer V, Lerchen H-G, et al. Preparation of benzofuran and benzothiophene derivatives useful in the treatment of cancers of the central nervous system. WO2008025509A120080306; 2008
41. Sahu R, Jaishree V, Ramesh B, et al. Cytotoxic studies of 3-(1-benzofuran-2- yl)-5-(substituted aryl) isoxazole. Internat J Pharm Appl 2011;2:115-21
42. Zhao J, Pu L-P, Yang J-T, et al. Cytotoxicity and reactive oxygen species related mechanism on HepG2 cells of two benzofuran derivatives. Chin J Exp Trad Med Form 2010;16:105-8
43. Yar MS, Abdullah MM, Husain A, et al. Synthesis and evaluation of in vitro antiviral activity of 2-[3-(substituted phenyl)-4,5-dihydro-1H-5- pyrazolyl] benzofuran-3-yl chloride derivatives. J Enzyme Inhib Med Chem 2009;24:949-56
44. Kim S, Hwang BY, Su B-N, et al. Silvestrol, a potential anticancer rocaglate derivative from Aglaia foveolata, induces apoptosis in LNCaP cells through the mitochondrial/apoptosome pathway without activation of executioner caspase-3 or -7. Anticancer Res 2007;27(4B):2175-83
45. Kossakowski J, Ostrowska K, Hejchman E, Wolska I. Synthesis and structural characterization of derivatives of 2- and 3-benzo[b]furan carboxylic acids with potential cytotoxic activity. Farmaco 2005;60:519-27
46. Takaya D, Yamashita A, Kamijo K, et al. A new method for induced fit docking (GENIUS) and its application to virtual screening of novel HCV NS3-4A protease inhibitors. Bioorg Med Chem 2011;19:6892-905
47. Paulson MS, Yang H, Shih I-H, et al. Comparison of HCV NS3 protease and NS5B polymerase inhibitor activity in 1a, 1b and 2a replicons and 2a infectious virus. Antivir Res 2009;83:135-42
48. Herlihy KJ, Graham JP, Kumpf R, et al. Development of intergenotypic chimeric replicons to determine the broad-spectrum antiviral activities of hepatitis C virus polymerase inhibitors. Antimicrob Agents Chemother 2008;52:3523-31
49. Herlihy KJ, Graham JP, Kumpf R, et al. Development of intergenotypic chimeric replicons to determine the broad-spectrum antiviral activities of hepatitis C virus polymerase inhibitors. Antimicrob Agents Chemother 2008;52:3523-31
50. Gopalsamy A, Aplasca A, Ciszewski G, et al. Design and synthesis of 3,4- dihydro-1H-[1]-benzothieno [2,3-c]pyran and 3,4-dihydro-1H-pyrano[3,4-b]- benzofuran derivatives as non-nucleoside inhibitors of HCV NS5B RNA dependent RNA polymerase. Bioorg Med Chem Lett 2006;16:457-60
51. Yeung K-S, Grant-Young KA, Kadow JF. Benzofuran-3-carboxamide derivatives and their preparation and use for the treatment of hepatitis C. US20120059019A120120308; 2012
52. Yeung K-S, Grant-Young KA, Kadow JF. Benzofuran-3-carboxamide derivatives and their preparation and use for the treatment of hepatitis C. WO2011112769A120110915; 2011
53. Salih KSM, Ayoub MT, Saadeh HA, et al. Synthesis, characterization, and biological activities of new benzofuran derivatives. Heterocycles 2007;71:1577-87
54. Rida SM, El-Hawash SAM, Fahmy HTY, et al. Synthesis of novel benzofuran and related benzimidazole derivatives for evaluation of in vitro anti- HIV-1, anticancer and antimicrobial activities. Arch Pharm Res 2006;29:826-33
55. Rida SM, El-Hawash SAM, Fahmy HTY, et al. Synthesis and in vitro evaluation of some novel benzofuran derivatives as potential anti-HIV-1, anticancer, and antimicrobial agents. Arch Pharm Res 2006;29:16-25
56. Galal SA, Abd El-All AS, Hegab KH, et al. Novel antiviral benzofuran-transition metal complexes. Eur J Med Chem 2010;45(7):3035-46
57. Liu B, Lee Y, Zou J, et al. Discovery and SAR of a series of 4,6-diamino-1,3,5- triazin-2-ol as novel non-nucleoside reverse transcriptase inhibitors of HIV-1. Bioorg Med Chem Lett 2010;20:6592-6
58. Ohshima E, Kawakita T, Yanagawa K, et al. Preparation of benzofuran or benzodioxole derivatives which possess PDE IV inhibitory activity. US20020128290A120020912; 2002
59. Grieg NH, Brossi A, Luo W, et al. Tetrahydrofurobenzofuran derivatives and their preparation pharmaceutical compositions and use as cholinesterase activity inhibitors. WO2006060082A120060608; 2006
60. He Y, Zeng LF, Yu ZH, et al. Bicyclic benzofuran and indole-based salicylic acids as protein tyrosine phosphatase inhibitors. Bioorg Med Chem 2012;20:1940-6
61. Pfefferkorn JA, Guzman-Perez A, Oates PJ, et al. Designing glucokinase activators with reduced hypoglycemia risk: Discovery of N,N-dimethyl-5-(2- methyl-6-((5-methylpyrazin-2-yl)- carbamoyl)benzofuran-4-yloxy) pyrimidine-2-carboxamide as a clinical candidate for the treatment of type 2 diabetes mellitus. Med Chem Comm 2011;2:828-39
62. Sidhu PS, Liang A, Mehta AY, et al. Rational design of potent, small, synthetic allosteric inhibitors of thrombin. J Med Chem 2011;54:5522-31
63. Shattat G, Al-Qirim T, Sweidan K, et al. The hypolipidemic activity of novel benzofuran-2-carboxamide derivatives in Triton WR-1339-induced hyperlipidemic rats: A comparison with bezafibrate. J Enzyme Inhib Med Chem 2010;25:751-5
64. Nguyen PH, Nguyen TNA, Dao TT, et al. AMP-Activated protein kinase (AMPK) activation by benzofurans and coumestans isolated from Erythrina abyssinica. J Nat Prod 2010;73:598-602
65. Negoro N, Terao Y, Mikami S, Yukawa T. Novel fused cyclic compounds as GPR40 receptor activators and their preparation and use in the treatment of diabetes. WO2010143733A120101216; 2010
66. Yasuma T, Negoro N, Yamashita M, Itou M. Preparation of biphenylmethoxybenzofurylacetates as GPR40 receptor modulators for treatment of diabetes. WO2008001931A220080103; 2008
67. Commons TJ, Croce SC, Woodworth RP, et al. Preparation of 6- arylamido(methyl)-naphthalen-2-yloxyacetic acid derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1). WO2003000649A120030103; 2003
68. Verghese J, Liang A, Sidhu PPS, et al. First steps in the direction of synthetic, allosteric, direct inhibitors of thrombin and factor Xa. Bioorg Med Chem Lett 2009;19:4126-9
69. Kawaguchi T, Akatsuka H, Iijima T, et al. Preparation of benzofuran derivatives as activated blood coagulation factor X inhibitors for treatment of thrombosis. JP2005120080A20050512; 2005
70. Kawaguchi T, Akatsuka H, Iijima T, et al. Preparation of benzofuran derivatives as activated blood coagulation factor X inhibitors for treatment of thrombosis. WO2003082847A120031009; 2003
71. Lu Z, Ott GR, Anand R, et al. Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-A converting enzyme (TACE): Discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents. Bioorg Med Chem Lett 2008;18:1958-62
72. Dixit M, Tripathi BK, Tamrakar AK, et al. Synthesis of benzofuran scaffold-based potential PTP-1B inhibitors. Bioorg Med Chem 2007;15:727-34
73. Saberi MR, Vinh TK, Yee SW, et al. Potent CYP19 (aromatase) 1- [(benzofuran-2-yl)-(phenylmethyl) pyridine, -imidazole, and -triazole inhibitors: Synthesis and biological evaluation. J Med Chem 2006;49:1016-22
74. Coskun D, Ahmedzade M, Kirbag S. 3- (Substituted aryl)-1-benzofuranyl-2- propenones: Antimicrobial properties of some chalcones-type compounds and their 2-pyrazoline derivatives. E Journal Chem 2011;8:1574-81
75. Bhimwal R, Sharma AK, Jain A. Synthesis, characterization and in-vitro antimicrobial evaluation of some novel isoxazoline derivatives. J Adv Pharm Edu Res 2011;(5):251-8
76. Jiang X, Liu W, Zhang W, et al. Synthesis and antimicrobial evaluation of new benzofuran derivatives. Eur J Med Chem 2011;46:3526-30
77. Bhovi VK, Bodke YD. Synthesis of some mannich bases and novel benzofuran derivatives containing imidazo[2,1-b] [1,3,4]thiadiazoles as biological agents. Curr Chem Biol 2010;4:145-50
78. Abdel-Aziz HA, Mekawey AAI, Dawood KM. Convenient synthesis and antimicrobial evaluation of some novel 2- substituted-3-methylbenzofuran derivatives. Eur J Med Chem 2009;44:3637-44
79. Abdel-Aziz HA, Mekawey AAI. Stereoselective synthesis and antimicrobial activity of benzofuran-based (1E)-1-(piperidin-1-yl)- N2-Arylamidrazones. Eur J Med Chem 2009;44:4985-97
80. Manna K, Agrawal YK. Microwave assisted synthesis of new indophenazine 1,3,5-trisubstituted pyrazoline derivatives of benzofuran and their antimicrobial activity. Bioorg Med Chem Lett 2009;19:2688-92
81. Cherkupally SR, Gurrala PR, Adki N, Avula S. Synthesis and biological study of novel methylene-bis-benzofuranyl- [1,5]-benzothiazepines. Org Commun 2008;1:84-94
82. El-Sawy ER, Shaker KH, Mandour AH, et al. Synthesis and pharmacological activities of novel furobenzopyrone and benzofuran derivatives. Indian J Chem 2008;47B:1451-62
83. Basavaraja KM, Vaidya VP, Chandrashekhar C. Synthesis of benzofuro[3,2-e]-1,4-diazepines of pharmacological interest. E Journal Chem 2008;5:567-71
84. Swamy PMG, Agasimundin YS. Synthesis and antimicrobial screening of certain substituted chalcones and isoxazolines bearing hydroxy benzofuran. Rasayan J Chem 2008;1:421-8
85. Koca M, Servi S, Kirilmis C, et al. Synthesis and antimicrobial activity of some novel derivatives of benzofuran: Part 1. Synthesis and antimicrobial activity of (benzofuran-2-yl)(3-phenyl-3- methylcyclobutyl) ketoxime derivatives. Eur J Med Chem 2005;40:1351-8
86. Babu VH, Kumar PS, Srinivasan KK, Bhat GV. Synthesis, antitumor and antibacterial activities of certain substituted pyrimidines bearing benzofuran. Indian J Pharm Sci 2004;66:647-52
87. Suthakaran R, Somasekhar G, Sridevi C, et al. Synthesis, anti-inflammatory, antioxidant and antibacterial activities of 7-methoxy benzofuran pyrazoline derivatives. Asian J Chem 2007;19:3353-62
88. Manna K, Agrawal YK. Potent in vitro and in vivo antitubercular activity of certain newly synthesized indophenazine 1,3,5-trisubstituted pyrazoline derivatives bearing benzofuran. Med Chem Res 2011;20:300-6
89. Manna K, Agrawal YK. Design, synthesis, and antitubercular evaluation of novel series of 3-benzofuran-5-Aryl-1- pyrazolylpyridylmethanone and 3- benzofuran-5-Aryl-1-pyrazolyl-carbonyl-4- oxo-naphthyridin analogs. Eur J Med Chem 2010;45:3831-9
90. Ravikumar S, Ramanathan G, Gnanadesigan M. In vitro antiplasmodial activity of spiro benzofuran compound from mangrove plant of Southern India. Asian Pacific J Trop Med 2012;5(5):358-61
91. Lebouvier N, Jullian V, Desvignes I, et al. Antiplasmodial activities of homogentisic acid derivative protein kinase inhibitors isolated from a Vanuatu marine sponge Pseudoceratina sp. Marine Drugs 2009;7:640-53
92. Bakunov SA, Bakunova SM, Bridges AS, et al. Synthesis and antiprotozoal properties of pentamidine congeners bearing the benzofuran motif. J Med Chem 2009;52:5763-7
93. Rindhe SS, Rode MA, Karale BK. New benzofuran derivatives as an antioxidant agent. Indian J Pharm Sci 2010;72:231-5
94. Meng X, Xin Z. Effect of hydrogen donating ability of benzofuranone on the antioxidant activity. Chin Sci Bull 2010;55:27-31
95. Javali C, Karvekar MD. Synthesis of N'- (substituted benzylidene)-1- benzofuran-2- carbohydrazide and 5-(5-substituted-1- benzofuran-2-yl)-1,3,4- oxadiazole-2-thiol as potent antioxidants. Asian J Chem 2008;20:4531-5
96. Babu VH, Sridevi C, Joseph A, Srinivasan KK. Synthesis and biological evaluation of some novel pyrazolines. Indian J Pharm Sci 2007;69:470-3
97. Lundgren CV, Koner AL, Tinkl M, et al. Reaction of singlet-excited 2,3- diazabicyclo[2.2.2]oct-2-ene and tert-butoxyl radicals with aryl-substituted benzofuranones. J Org Chem 2006;71:1977-83
98. Huang Z, Liu Y, Li Y, et al. Synthesis, crystal structures, insecticidal activities, and structure-Activity relationships of novel Ń-tert-Butyl- Ń-substitutedbenzoyl- N-[di(octa)hydro]benzofuran {(2,3-dihydro)benzo[1, 3]([1,4])dioxine} carbohydrazide derivatives. J Agric Food Chem 2011;59:635-44
99. Jackson YA, Williams MF, Williams LAD, et al. Insecticidal properties of benzofuran-2-carboxylic acid derivatives. Pesticide Sci 1998;53:241-4
100. Lee S-M, Lee W-G, Kim Y-C, Ko H. Synthesis and biological evaluation of a,b-unsaturated lactones as potent immunosuppressive agents. Bioorg Med Chem Lett 2011;21:5726-9
101. Ameta KL, Rathore NS, Kumar B, et al. Synthesis and trypanocidal evaluation of some novel 2-(substituted benzylidene)- 5,7-dibromo-6-hydroxy-1- benzofuran-3 (2H)-ones. Internat J Org Chem 2012;2:295-301
102. Yoneda F, Watabe M, Oka T, Yasusa T. Process for preparing optically active (R)-1-(benzofuran-2-yl)-2-(propylamino) pentane. JP4691230B220110601; 2011
103. Yoneda F, Watanabe M, Yasusa T. Process for production of optically active 1-Aryl-2-propylaminopentane derivatives and optically active 3,4-dipropyl- 1,2,3-oxathiazolidine 2,2-dioxide as intermediates therefore. WO2007001015A120070104; 2007
104. Yoneda F, Ohde H, Watanabe M, et al. Compositions containing 1-(benzofuran- 2-yl)-2-propylaminopentane for transdermal or transmucosal administration. WO2008156160A120081224; 2008
105. Hoshino T, Yanagida H, Yamamoto N. Anti-influenza virus agents and anti-influenza drugs containing heterocyclic compounds, methyl benzoate derivative, or thienopyrimidine compounds, and prevention and/or treatment of influenza virus infection by these compounds. JP2012121822A20120628; 2012
106. Flynn BL, Baell JB, Harvey AJ, et al. Preparation of benzofuran derivatives for use as potassium channel blockers. WO2008040057A120080410; 2008
107. Iida K, Hagiwara K, Kashima S, et al. Preparation of benzofuran derivatives as adrenaline a2c receptor antagonists. JP2005139106A20050602; 2005